BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30476471)

  • 1. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
    Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
    Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome.
    Tamm M; Aboyoun CL; Chhajed PN; Rainer S; Malouf MA; Glanville AR
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1120-3. PubMed ID: 15297275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
    Mabilangan C; Preiksaitis J; Cervera C;
    Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
    Mabilangan C; Preiksaitis JK; Cervera C;
    Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients.
    Vutien P; Perkins J; Biggins SW; Reyes J; Imlay H; Limaye AP
    Liver Transpl; 2021 Sep; 27(9):1302-1311. PubMed ID: 33687777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
    Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postlung transplant survival is equivalent regardless of cytomegalovirus match status.
    Russo MJ; Sternberg DI; Hong KN; Sorabella RA; Moskowitz AJ; Gelijns AC; Wilt JR; D'Ovidio F; Kawut SM; Arcasoy SM; Sonett JR
    Ann Thorac Surg; 2007 Oct; 84(4):1129-34; discussion 1134-5. PubMed ID: 17888958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.
    Danziger-Isakov LA; Worley S; Michaels MG; Arrigain S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet S; Faro A
    Transplantation; 2009 May; 87(10):1541-8. PubMed ID: 19461492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Griffith J; Ruthazer R; Werner BG
    Ann Intern Med; 1997 Feb; 126(4):275-9. PubMed ID: 9036799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in pediatric lung transplant recipients receiving adult allografts.
    Hayes D; McConnell PI; Galantowicz M; Whitson BA; Tobias JD; Black SM
    Ann Thorac Surg; 2015 Apr; 99(4):1184-91. PubMed ID: 25707585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus and long-term outcome after lung transplantation in Gothenburg, Sweden.
    Johanssson I; Mårtensson G; Andersson R
    Scand J Infect Dis; 2010; 42(2):129-36. PubMed ID: 20082575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients.
    Cerrina J; Le Roy Ladurie F; Herve PH; Parquin F; Harari S; Chapelier A; Simoneau G; Vouhe P; Dartevelle PH
    Transpl Int; 1992; 5 Suppl 1():S242-5. PubMed ID: 14621790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients.
    Kawashima M; Ma J; Huszti E; Levy L; Berra G; Renaud-Picard B; Takahagi A; Ghany R; Sato M; Keshavjee S; Singer L; Husain S; Kumar D; Tikkanen J; Martinu T
    Am J Transplant; 2024 Jun; 24(6):1057-1069. PubMed ID: 38307417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended recipients but not extended donors are associated with poor outcomes following lung transplantation.
    Moreno P; Alvarez A; Santos F; Vaquero JM; Baamonde C; Redel J; Cerezo F; Algar FJ; Salvatierra A
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1040-7. PubMed ID: 24163362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatically Brain-Injured Donors and the Impact on Lung Transplantation Survival.
    Crawford TC; Lui C; Magruder JT; Suarez-Pierre A; Ha JS; Higgins RS; Broderick SR; Merlo CA; Kim BS; Bush EL
    Ann Thorac Surg; 2018 Sep; 106(3):842-847. PubMed ID: 29730351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.